These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19025433)

  • 61. [Treatment of low cardiac output by phosphodiesterase inhibitors].
    Lançon JP; Caillard B
    Agressologie; 1991; 32(1):81-2. PubMed ID: 2063988
    [No Abstract]   [Full Text] [Related]  

  • 62. Initiation and use of beta-blockers in class IV heart failure.
    Bader FM; MacGregor JF; Gilbert EM
    Curr Heart Fail Rep; 2004 Jul; 1(2):72-6. PubMed ID: 16036028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of beta3-adrenergic receptor agonists in the treatment of heart failure.
    Rasmussen HH; Figtree GA; Krum H; Bundgaard H
    Curr Opin Investig Drugs; 2009 Sep; 10(9):955-62. PubMed ID: 19705338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Making sense of SENIORS.
    McMurray J
    Eur Heart J; 2005 Feb; 26(3):203-6. PubMed ID: 15647290
    [No Abstract]   [Full Text] [Related]  

  • 66. Cardiac protection during acute myocardial infarction.
    Dubois C
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):19-21. PubMed ID: 19618593
    [No Abstract]   [Full Text] [Related]  

  • 67. Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia.
    Menniti FS; Chappie TA; Humphrey JM; Schmidt CJ
    Curr Opin Investig Drugs; 2007 Jan; 8(1):54-9. PubMed ID: 17263185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacogenetics in heart failure: promises and challenges.
    de Boer RA; van der Harst P; van Veldhuisen DJ; van den Berg MP
    Expert Opin Pharmacother; 2009 Aug; 10(11):1713-25. PubMed ID: 19558337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The use of beta blockaders in chronic heart failure shows how important the application of evidence based medicine really is].
    Swedberg K; Skoglund I
    Lakartidningen; 2005 Feb 21-27; 102(8):580. PubMed ID: 15786913
    [No Abstract]   [Full Text] [Related]  

  • 70. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heart rate variability.
    Bilchick KC; Berger RD
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):691-4. PubMed ID: 16836727
    [No Abstract]   [Full Text] [Related]  

  • 72. Treating heart failure with sildenafil.
    Blum A
    Congest Heart Fail; 2009; 15(4):181-5. PubMed ID: 19627292
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The pharmacology of bronchiolar muscle relaxation.
    van den Brink FG
    Bull Physiopathol Respir (Nancy); 1972; 8(3):475-87. PubMed ID: 4405128
    [No Abstract]   [Full Text] [Related]  

  • 74. Anaemia and renal dysfunction in chronic heart failure.
    van der Meer P; van Veldhuisen DJ
    Heart; 2009 Nov; 95(21):1808-12. PubMed ID: 19828825
    [No Abstract]   [Full Text] [Related]  

  • 75. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Dunkelgrun M; Boersma E; Schouten O; Koopman-van Gemert AW; van Poorten F; Bax JJ; Thomson IR; Poldermans D;
    Ann Surg; 2009 Jun; 249(6):921-6. PubMed ID: 19474688
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The role of cytokine system in pathogenesis of chronic cardiac insufficiency].
    Ol'binskaia LI; Ignatenko SB
    Ter Arkh; 2001; 73(12):82-4. PubMed ID: 11858119
    [No Abstract]   [Full Text] [Related]  

  • 77. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 78. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical analysis of the effect of beta-blocker receptors in patients with chronic heart failure].
    Li B; Hu YM; Su XY; Hu YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):251-2. PubMed ID: 17448290
    [No Abstract]   [Full Text] [Related]  

  • 80. [Update: Current clinical developments in pulmonary hypertension].
    Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.